Out on PubMed, from a clinician in Iraq, is this case report: Role of Cariprazine in Managing and Preventing Refractory Catatonia: A Case Study. Qasab ZA. Cureus. 2024 Sep 30;16(9):e70538. doi: 10.7759/cureus.70538. eCollection 2024 Sep. PMID: 39479081 The abstract is copied below: This case study explores the management of a 22-year-old male patient diagnosed with recurrent refractory catatonia, a neuropsychiatric condition characterized by motor, behavioral, and autonomic disturbances often associated with bipolar disorder. Despite comprehensive investigations, including normal results in tests such as complete blood count (CBC), liver function tests (LFT), thyroid function tests (TFT), renal function tests (RFT), C-reactive protein (CRP), creatine kinase (CKP), and serum electrolytes, the patient's condition persisted. Initial treatments with conventional therapies, such as benzodiazepines, proved unsuccessful. However, the introduction of cariprazine, an atypical antipsych